It has been previously described that the reduction of systemic inflammation in this experimental model of colitis is mediated by the induction of regulatory CD25+Foxp3+CD4+ T cells in the colon and mLNs [33,46] together with a reduction in the levels of IL17 in the lamina propria mononuclear cells [45]. This evidence concerns the gene FOXP3 and colitis.